Halogenated Nucleosides
6-Cl-purine-2'-deoxyriboside
Quick view. We supply 6-Cl-purine-2'-deoxyriboside as a halogenated nucleoside analog for modified nucleoside, antiviral/antimetabolite and oligonucleotide precursor research. CAS 4594-45-0. Catalog target purity: ≥98%.

Product profile
6-Cl-purine-2'-deoxyriboside is classified as nucleoside or protected nucleoside intermediate (Formula C10H11ClN4O3; molecular weight 270.67).
6-Cl-purine-2'-deoxyriboside — 6-Chloropurine 2'-deoxyriboside is used in the synthesis of 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine.
For 6-Cl-purine-2'-deoxyriboside, storage: Sealed in dry,2-8°C. Form: Powder.
Names and search terms
Confirmed or normalized name variants
- 6-Cl-deoxyriboside
- 6-CHLOROPURINE DEOXYRIBOSIDE
- 6-CHLOROPURINE-2'-DEOXYRIBOSIDE
- 6-chloro-9-(2-deoxy-β-D-erythro-
- 6-Chloro-9-(2'-deoxyribofuranosyl) purine
- 6-CHLOROPURINE-2'-DEOXYRIBOSIDE USP/EP/BP
- 6-Chloropurine 2’-deoxy--D-ribofuranoside
- 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine
Useful catalog search terms
- CAS 4594-45-0
- Nucleoside or protected nucleoside intermediate
- Halogenated Nucleosides
Physicochemical data
| Boiling point | 568.0±60.0 °C(Predicted) |
|---|---|
| Density | 1.88±0.1 g/cm3(Predicted) |
| pKa | 13.76±0.60(Predicted) |
| Form | Powder |
| Color | White to Off-white |
| SMILES | N1(C=NC2C(Cl)=NC=NC1=2)[C@H]1C[C@H](O)[C@@H](CO)O1 |&1:10,12,14,r| |
| InChI | InChI=1/C10H11ClN4O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2/t5-,6+,7+/s |
| InChIKey | PGEULCIODBNODW-QXWMLGDLNA-N |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- 6-Cl-purine-2'-deoxyriboside can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
2'-5-CF3-dU
Halogenated Nucleosides · CAS: 70-00-8
BX-HN-00038-Cl-2'-dA
Halogenated Nucleosides · CAS: 85562-55-6
BX-HN-00042'-Chloro-2'-deoxycytidine
Halogenated Nucleosides · CAS: 10212-19-8
BX-HN-00055-bromo-2'-deoxycytidine
Halogenated Nucleosides · CAS: 1022-79-3
BX-HN-00065-Iodouridine
Halogenated Nucleosides · CAS: 1024-99-3
BX-HN-01535-fluoro-2'-deoxycytidine
Halogenated Nucleosides · CAS: 10356-76-0
Frequently asked questions
Can the package size for 6-Cl-purine-2'-deoxyriboside be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-HN-0002 and CAS 4594-45-0, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Halogenated Nucleosides product family and its named chemistry.
